Quantitative Comparison of HSF1 Activators

被引:1
|
作者
Steurer, Christoph [1 ]
Kerschbaum, Sarah [1 ]
Wegrostek, Christina [1 ]
Gabriel, Stefan [1 ]
Hallaj, Ali [1 ]
Ortner, Viktoria [1 ]
Czerny, Thomas [1 ]
Riegel, Elisabeth [1 ]
机构
[1] Univ Appl Sci, Dept Appl Life Sci, FH Campus Wien,Helmut Qualtinger Gasse 2, A-1030 Vienna, Austria
关键词
Heat shock response; Neurodegenerative disease; HSF1; Luciferase assay; HEAT-SHOCK PROTEINS; TRANSCRIPTION FACTOR HSF1; ANTIINFLAMMATORY DRUGS; FACTOR-I; HYDROGEN-PEROXIDE; HUMAN-CELLS; CO-INDUCER; KAPPA-B; INDUCTION; STRESS;
D O I
10.1007/s12033-022-00467-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The heat shock response (HSR) pathway is a highly conserved rescue mechanism, which protects the cells from harmful insults disturbing the cellular protein homeostasis via expression of chaperones. Furthermore, it was demonstrated to play crucial roles in various diseases like neurodegeneration and cancer. For neurodegenerative diseases, an overexpression of chaperones is a potential therapeutic approach to clear the cells from non-functional protein aggregates. Therefore, activators of the HSR pathway and its master regulator HSF1 are under close observation. There are numerous HSR activators published in the literature using different model systems, experimental designs, and readout assays. The aim of this work was to provide a quantitative comparison of a broad range of published activators using a newly developed HSF responsive dual-luciferase cell line. Contrary to natural target genes, which are regulated by multiple input pathways, the artificial reporter exclusively reacts to HSF activity. In addition, the results were compared to endogenous heat shock protein expression. As a result, great differences in the intensity of pathway activation were observed. In addition, a parallel viability assessment revealed high variability in the specificity of the drugs. Furthermore, the differences seen compared to published data indicate that some activators exhibit tissue-specific differences leading to interesting assumptions about the regulation of HSF1.
引用
收藏
页码:873 / 887
页数:15
相关论文
共 50 条
  • [1] Quantitative Comparison of HSF1 Activators
    Christoph Steurer
    Sarah Kerschbaum
    Christina Wegrostek
    Stefan Gabriel
    Ali Hallaj
    Viktoria Ortner
    Thomas Czerny
    Elisabeth Riegel
    [J]. Molecular Biotechnology, 2022, 64 : 873 - 887
  • [2] HSF1 in Translation
    de Billy, Emmanuel
    Clarke, Paul A.
    Workman, Paul
    [J]. CANCER CELL, 2013, 24 (02) : 147 - 149
  • [3] HSF1 at a glance
    Vihervaara, Anniina
    Sistonen, Lea
    [J]. JOURNAL OF CELL SCIENCE, 2014, 127 (02) : 261 - 266
  • [4] Transcription repression by HSF1
    Xie, Y
    Chen, CM
    Calderwood, SK
    [J]. FASEB JOURNAL, 2001, 15 (05): : A1224 - A1224
  • [5] HSF1 as a mitotic regulator: Phosphorylation of HSF1 by Plk1 is essential for mitotic progression
    Lee, Yoon-Jin
    Kim, Eun-Ho
    Lee, Jae Seon
    Jeoung, Dooil
    Bae, Sangwoo
    Kwon, Seung Hae
    Lee, Yun-Sil
    [J]. CANCER RESEARCH, 2008, 68 (18) : 7550 - 7560
  • [6] Hsf1 Knock-out
    Christians, Elisabeth
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (48) : LE26 - LE26
  • [7] Expression of HSF1 in astrocytic tumors
    Moutafidi, Athanasia
    Zolota, Vassiliki
    Assimakopoulou, Martha
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 : S12 - S12
  • [8] HSF1, A Versatile Factor in Tumorogenesis
    Calderwood, S. K.
    [J]. CURRENT MOLECULAR MEDICINE, 2012, 12 (09) : 1102 - 1107
  • [9] Multifaceted roles of HSF1 in cancer
    Jiang, Sufang
    Tu, Kailing
    Fu, Qiang
    Schmitt, David C.
    Zhou, Lan
    Lu, Na
    Zhao, Yuhua
    [J]. TUMOR BIOLOGY, 2015, 36 (07) : 4923 - 4931
  • [10] The Multifaceted Role of HSF1 in Tumorigenesis
    Alasady, Milad J.
    Mendillo, Marc L.
    [J]. HSF1 AND MOLECULAR CHAPERONES IN BIOLOGY AND CANCER, 2020, 1243 : 69 - 85